-
U.S. Govt. Selects Grand River Aseptic Manufacturing to Help Combat COVID-19
contractpharma
August 11, 2020
HHS and Dept. of Defense call upon the U.S.-based CDMO to expand domestic fill/finish capacity under Operation Warp Speed.
-
Sekisui Invests $18.93 Million in Biopharma CDMO Business
contractpharma
August 03, 2020
Sekisui has invested £14.4 million ($18.93 million) in its biopharma CDMO business aimed at cGMP microbial capacity expansion at the existing site in Maidstone, Kent to be completed by the second half of 2022.
-
Forge Biologics Completes Series A Financing
contractpharma
August 03, 2020
The company is advancing development candidates for the treatment of Krabbe disease.
-
Avid Bioservices, Argonaut Enter Manufacturing Services Pact
contractpharma
July 29, 2020
To offer integrated process development, drug substance manufacturing and drug product parenteral manufacturing.
-
GenScript Expands CDMO Capabilities
contractpharma
July 24, 2020
Launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum in Shanghai.
-
Bora Adds Four Business Development Directors
contractpharma
July 24, 2020
Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO) which specializes in immediate and modified release tablets and capsules, along with serialized packaging, has appointed four business development directors..
-
Polpharma Fully Integrates Bioceros
contractpharma
July 16, 2020
In 2016, Polpharma Biologics acquired Dutch based Bioceros and their proprietary cell line development platform CHOBC, as well as their discovery, process development and analytical capabilities.
-
Vetter Further Expands its Development Service with New Site in Austria
b3cnewswire
July 09, 2020
With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill and finish solutions.
-
Rentschler Biopharma and Vetter Enter Partnership
contractpharma
July 07, 2020
Two CDMOs team up with joint goal to simplify processes and optimize time-to-market.
-
GRAM Opens Large-Scale Injectable Fill/Finish Facility
contractpharma
July 06, 2020
Grand River Aseptic Manufacturing (GRAM), an agile and modern parenteral contract development and manufacturing organization (CDMO), completed its major $60 million expansion project and recently took occupancy.